Intravenous propofol: unique effectiveness in treating intractable migraine (Q33897701)

29 July 2017

title

Intravenous propofol: unique effectiveness in treating intractable migraine (English)

1 reference

29 July 2017

1 reference

1 reference

Krusz JC

1

1 reference

29 July 2017

Scott V

series ordinal

2

1 reference

29 July 2017

Belanger J

series ordinal

3

1 reference

29 July 2017

publication date

1 March 2000

1 reference

29 July 2017

1 reference

29 July 2017

volume

40

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

224-230

1 reference

Subhypnotic doses of propofol possess direct antiemetic properties

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00032.X

Effect of propofol on spinal dorsal horn neurons. Comparison with lack of ketamine effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00032.X

Sympathetic responses to induction of anesthesia in humans with propofol or etomidate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00032.X

Propofol stimulates nitric oxide release from cultured porcine aortic endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00032.X

Inhibitory effects of thiopental, ketamine, and propofol on voltage-dependent Ca2+ channels in porcine tracheal smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00032.X

In vivo and in vitro studies of the inhibitory effect of propofol on human platelet aggregation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00032.X

Inhibition by propofol (2,6 di-isopropylphenol) of the N-methyl-D-aspartate subtype of glutamate receptor in cultured hippocampal neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00032.X

Potentiation, activation and blockade of GABAA receptors of clonal murine hypothalamic GT1-7 neurones by propofol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00032.X

The actions of propofol on inhibitory amino acid receptors of bovine adrenomedullary chromaffin cells and rodent central neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00032.X

Modulatory and direct effects of propofol on recombinant GABAA receptors expressed in xenopus oocytes: influence of alpha- and gamma2-subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00032.X

Propofol modulates the effects of chemoconvulsants acting at GABAergic, glycinergic, and glutamate receptor subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00032.X

Topographic electroencephalogram of propofol-induced conscious sedation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00032.X

Cerebral metabolism during propofol anesthesia in humans studied with positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00032.X

Propofol. An overview of its pharmacology and a review of its clinical efficacy in intensive care sedation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00032.X

Wolff Award 1996. The actions of valproate and neurosteroids in a model of trigeminal pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00032.X

Is intravenous lidocaine clinically effective in acute migraine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2000.00032.X

10.1046/J.1526-4610.2000.00032.X

21 January 2018

Identifiers

DOI

1 reference

29 July 2017

1 reference